Certification is possible provided that
Acceptable DOACs are Dabigatran, Rivaroxaban and Apixaban.
Likely indications include:
Prior to certification, for pilots taking warfarin the INR should be demonstrated to be within the target range for 6 months (4 results at 2 monthly intervals) and 2 monthly laboratory testing should be continued on an ongoing basis. If the INR varies considerably within the target range on the initial readings, a longer period of surveillance may be required. Pilots taking DOACs should be free of side effects for a period of 3 months prior to fitness reassessment.
Class 1 applicants treated with warfarin are required to measure their INR on a ‘near patient’ testing system (such as CoaguChek S) 12 hours prior to flight and only fly if the INR is within the target range. The INR should be recorded in the Log Book. The Log Book should be reviewed at each medical certificate revalidation examination.
For LAPL pilots, a shorter period of stabilisation (6 weeks for DOACs and 4 months for warfarin) may be acceptable provided there are no side effects and there is reliable evidence of INR stability in pilots taking warfarin.
If you are a passenger affected by the failure of the Austrian airline Fly NIKI you can find more information here… https://t.co/VuhJLDXvlZ
35 minutes ago
We are now recruiting an airworthiness policy specialist, to be based at our Gatwick office. https://t.co/LGG4WYDVfS
2 hours ago
If you flight is currently affected by weather-related disruption, find out your rights here https://t.co/CQfuZXtKKI
4 days ago
Read all @UK_CAA
e-Licensing becomes reality for commercial pilots
4 December, 2017
Drones flying high with 1.5 million to be sold this Christmas; CAA reminds users of the need to follow safety rules
2 December, 2017
Civil Aviation Authority response to Heathrow Airport noise footprint report
1 December, 2017
Read all News
‘Share the Air’ gets off to a flying start
1 December, 2017
Access to air travel
11 August, 2017
International women in engineering day
22 June, 2017
Read All Blogs